| DODGX | VGRIX | DODGX / VGRIX | |
| Total Expense Ratio | 0.51 | 0.94 | 54% |
| Annual Report Gross Expense Ratio | 0.51 | 1.00 | 51% |
| Fund Existence | 61 years | 38 years | - |
| Gain YTD | 5.365 | 10.088 | 53% |
| Front Load | N/A | 5% | - |
| Min. Initial Investment | 2500 | 1000 | 250% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 119B | 6.57B | 1,813% |
| Annual Yield % from dividends | 1.32 | 1.05 | 125% |
| Returns for 1 year | 3.81 | 8.45 | 45% |
| Returns for 3 years | 30.00 | 35.57 | 84% |
| Returns for 5 years | 48.93 | 64.74 | 76% |
| Returns for 10 years | 74.45 | 121.04 | 62% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| VAPPX | 24.16 | 0.01 | +0.04% |
| VALIC Company I Capital Appreciation | |||
| FKDNX | 189.72 | -0.26 | -0.14% |
| Franklin DynaTech A | |||
| ALARX | 55.14 | -0.09 | -0.16% |
| Alger Capital Appreciation Instl I | |||
| TSLTX | 5.26 | -0.01 | -0.19% |
| Transamerica Small Cap Value I3 | |||
| FRBRX | 181.45 | -1.51 | -0.83% |
| Franklin Biotechnology Discovery R6 | |||